Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Permanently Discontinued

JAMP-METHOTREXATE

JAMP PHARMA CORPORATION

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is JAMP-METHOTREXATE discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that JAMP-METHOTREXATE 25MG has been permanently discontinued (last updated October 7, 2022). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is JAMP-METHOTREXATE not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

Can I still get this?Possibly — same-ingredient product records found
StatusPermanently Discontinued
Same-ingredient products on file6 products · 3 same form & route
Affected strength25MG
Report last updated2022-10-07
Checked by MedShort2026-11-13

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

METHOTREXATE INJECTION USP

PFIZER CANADA ULC

25MG · DIN 02182777

Same strengthSame dosage formSame routeNo current shortage

METHOTREXATE INJECTION BP

ACCORD HEALTHCARE INC

25MG · DIN 02327236

Same strengthSame dosage formSame routeNo current shortage

Other Products

METHOTREXATE INJECTION, BP

PHARMASCIENCE INC

7.5MG · DIN 02422166

Different strengthSame dosage formSame routeNo current shortage

METOJECT SUBCUTANEOUS

MEDEXUS PHARMACEUTICALS INC.

22.5MG · DIN 02454777

Different strengthSame dosage formDifferent routeNo current shortage

PMS-METHOTREXATE INJECTION

PHARMASCIENCE INC

15MG · DIN 02539624

Different strengthSame dosage formDifferent routeNo current shortage

METHOFILL SELF-DOSE INJECTOR

ACCORD HEALTHCARE INC

22.5MG · DIN 02530848

Different strengthSame dosage formDifferent routeNo current shortage

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

⚠ Possible Recall or Safety Alert

Health Canada has issued a recall or safety alert matching this product. This match is based on product name similarity and may not be exact — confirm against your specific lot number before taking action.

DIN

02419173

Strength

25MG

Dosage Form

SOLUTION

Route

INTRA-ARTERIAL INTRAMUSCULAR INTRATHECAL INTRAVENOUS

Active Ingredient

METHOTREXATE

See all METHOTREXATE products →

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History